Govzilla and FOI Services Announce Strategic Partnership

Govzilla and FOI Services announced Tuesday, April 16th, 2019 the beginning of their official partnership that integrates FOI Services’ unique and vast dataset with Govzilla’s innovative analytics tools to help solve regulatory intelligence problems. FDA regulated industries' need for immediate access to enforcement documents is growing as more companies expand [...]

By |April 18th, 2019|Categories: FDAzilla|0 Comments

Week of March 31st, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Enforcement in terms of warning letter posting was busy this week. Among those issued were four that were sent to homeopathic drug product manufacturers, continuing a focus evident over the past two years. In addition, there were another two to drug product manufacturers and one to an in vitro diagnostics firm.

Week of March 25, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

We cover four warning letters from last week including two to pharmaceutical firms and two to compounding facilities. The FDA has not yet published the warning letter issued to Lupin Pharmaceuticals that the firm disclosed a couple weeks ago.

Search by Category


Top Posts

How can we help you?

Copyright ® 2010-2018 – and Govzilla, Inc., All rights reserved. Unauthorized publication is strictly prohibited.